Mitral Valve

The heart's mitral valve is the site of the most surgical valve repairs and valve replacements. After the resounding success of transcatheter aortic valve replacement (TAVR), which now makes up more than 50% of aortic valve replacements, there is wide expectation transcatheter mitral replacements will follow in the next few year. Currently, the most common transcatheter mitral procedure is transcatheter edge-to-edge (TEER) , using the MitraClip or Pascal clip devices. These devices are also being used for transcatheter tricuspid valve repair (TTVR). Other transcatheter mitral repair systems are in trials for minimally invasive annuloplasty and chordae tendineae repair.

FDA grants breakthrough device designation to new TMVR device from 4C Medical
The supra-annular AltaValve System was designed to treat both primary and secondary mitral regurgitation. It is implanted via transseptal access and positioned above the native mitral valve.
Cardiologists and surgeons perform world’s first robot-assisted TEER
A 62-year-old women presented with severe MR and recurrent heart failure episodes. Initial data suggest the procedure was a success.
Society of Thoracic Surgeons launches new risk calculators for SAVR after TAVR, other key heart surgeries
STS risk calculators are known as a go-to resource for cardiologists, surgeons and any other healthcare providers who manage the care of heart patients.
TMVR vs. mitral valve surgery: Tendyne linked to improved survival in elderly patients
New data out of Germany suggest TMVR can offer intermediate-risk patients a safe alternative to surgery.
Data registries have been a huge success for U.S. structural heart programs
ACC/STS National Cardiovascular Data Registry metrics reporting for TAVR is important for marketing and care quality, explains Patricia Keegan, NP, with the Emory Heart and Vascular Center.

Significant MR after TAVR linked to higher mortality rates—but staged interventions may help

Percutaneous edge-to-edge mitral valve repair was associated with improved outcomes among TAVR patients with persistent mitral regurgitation.

May 14, 2021

When TEER fails, most patients require mitral valve replacement

The team's findings were presented at the 101st Annual Meeting of the American Association for Thoracic Surgery and published in the Journal of the American College of Cardiology.

May 3, 2021

USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.

Transseptal MViV for high-risk patients associated with 100% success rate after 1 year

Researchers explored data from one arm of the MITRAL early feasible study, sharing their findings in JACC: Cardiovascular Interventions.

April 22, 2021

Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.

TEER still beneficial for heart failure patients with an elevated mitral valve gradient

Researchers explored data from the COAPT trial, sharing their findings in JACC: Cardiovascular Interventions.

April 20, 2021

New guidelines focus on the management of heart failure patients with secondary mitral regurgitation

The Heart Failure Association, European Association of Cardiovascular Imaging, European Heart Rhythm Association and European Association of Percutaneous Cardiovascular Interventions all collaborated on the position statement.

April 8, 2021